Economic evaluations of novel antipsychotic medications: a literature review-Reference-Cited by-同舟云学术

Economic evaluations of novel antipsychotic medications: a literature review

Published:2003-04 Issue:2-3 Volume:60 Page:199-218
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Hudson Teresa J,Sullivan Greer,Feng Weiwei,Owen Richard R,Thrush Carol R

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference58 articles.

1. Reduction of healthcare resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy;Albright;Clin. Pharmacoecon.,1996

2. Cost analysis of the treatment of schizophrenia in the UK: comparison of olanzapine and haloperidol;Almond;PharmacoEconomics,1998

3. Cost analysis of the treatment of schizophrenia in the UK: a simulation model comparing olanzapine, risperidone, and haloperidol;Almond;PharmacoEconomics,2000

4. Practice guideline for the treatment of patients with schizophrenia;Am. J. Psychiatry,1997

5. Quality of life and new antipsychotics in schizophrenia. Are patients better off?;Awad;Int. J. Soc. Psychiatry,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kosteneffektivität der Behandlung (Modul 6);S3-Leitlinie Schizophrenie;2019

2. ATYPICAL ANTIPSYCHOTICS FROM SCRATCH TO THE PRESENT;International journal of pharmaceutical sciences and research;2013-01-01

3. Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China;Value in Health;2009-11

4. The effect of newer drugs on health spending: do they really increase the costs?;Health Economics;2009

5. The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs?;SSRN Electronic Journal;2008